NCT00723216View on ClinicalTrials.gov

Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

151

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Abdominal Neoplasms

Interventions

DRUG

enoxaparin

20 mg twice a day

OTHER

Physical prophylaxis

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00723216 - Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery | Biotech Hunter | Biotech Hunter